Remaining Obstacles to the Success of Cancer Gene Therapy

Malcolm K. Brenner

doi:10.1002/9781118501665.ch9

Remaining Obstacles to the Success of Cancer Gene Therapy

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Earlier chapters in this book have described the technologies used for gene transfer and the manufacturing and regulatory requirements required to safely and legally exploit these technologies. This final chapter describes some of the obstacles to developing gene therapies from these early-phase clinical studies so that they can become licensed agents that are standards of practice as cancer therapeutics. Also outline are some of the remaining scientific limitations that will need to be addressed if gene therapies are to reach their broadest potential.

Original language	English (US)
Title of host publication	Cancer Gene Therapy by Viral and Non-viral Vectors
Publisher	Wiley
Pages	151-156
Number of pages	6
ISBN (Electronic)	9781118501665
ISBN (Print)	9781118501627
DOIs	https://doi.org/10.1002/9781118501665.ch9
State	Published - Mar 17 2014

Keywords

Cell therapy for cancer
Clinical trial design for biologicals
Drug development using biologicals
Gene therapy for cancer

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/9781118501665.ch9

Cite this

@inbook{0515b382aedf43c9b3e45d0c54921373,

title = "Remaining Obstacles to the Success of Cancer Gene Therapy",

abstract = "Earlier chapters in this book have described the technologies used for gene transfer and the manufacturing and regulatory requirements required to safely and legally exploit these technologies. This final chapter describes some of the obstacles to developing gene therapies from these early-phase clinical studies so that they can become licensed agents that are standards of practice as cancer therapeutics. Also outline are some of the remaining scientific limitations that will need to be addressed if gene therapies are to reach their broadest potential.",

keywords = "Cell therapy for cancer, Clinical trial design for biologicals, Drug development using biologicals, Gene therapy for cancer",

author = "Brenner, {Malcolm K.}",

year = "2014",

month = mar,

day = "17",

doi = "10.1002/9781118501665.ch9",

language = "English (US)",

isbn = "9781118501627",

pages = "151--156",

booktitle = "Cancer Gene Therapy by Viral and Non-viral Vectors",

publisher = "Wiley",

address = "United Kingdom",

}

TY - CHAP

T1 - Remaining Obstacles to the Success of Cancer Gene Therapy

AU - Brenner, Malcolm K.

PY - 2014/3/17

Y1 - 2014/3/17

N2 - Earlier chapters in this book have described the technologies used for gene transfer and the manufacturing and regulatory requirements required to safely and legally exploit these technologies. This final chapter describes some of the obstacles to developing gene therapies from these early-phase clinical studies so that they can become licensed agents that are standards of practice as cancer therapeutics. Also outline are some of the remaining scientific limitations that will need to be addressed if gene therapies are to reach their broadest potential.

AB - Earlier chapters in this book have described the technologies used for gene transfer and the manufacturing and regulatory requirements required to safely and legally exploit these technologies. This final chapter describes some of the obstacles to developing gene therapies from these early-phase clinical studies so that they can become licensed agents that are standards of practice as cancer therapeutics. Also outline are some of the remaining scientific limitations that will need to be addressed if gene therapies are to reach their broadest potential.

KW - Cell therapy for cancer

KW - Clinical trial design for biologicals

KW - Drug development using biologicals

KW - Gene therapy for cancer

UR - http://www.scopus.com/inward/record.url?scp=84927127609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927127609&partnerID=8YFLogxK

U2 - 10.1002/9781118501665.ch9

DO - 10.1002/9781118501665.ch9

M3 - Chapter

AN - SCOPUS:84927127609

SN - 9781118501627

SP - 151

EP - 156

BT - Cancer Gene Therapy by Viral and Non-viral Vectors

PB - Wiley

ER -

Remaining Obstacles to the Success of Cancer Gene Therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this